Stockreport

Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik

Cartesian Therapeutics, Inc.  (RNAC) 
PDF GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRN [Read more]